COMMUNIQUÉS West-GlobeNewswire

Ose Immunotherapeutics : Documents made available to the shareholders for the combined general meeting of June 25th, 2025
04/06/2025
Documents made available to the shareholders for the combined general meeting of June 25 th , 2025 Nantes, June 4 th , 2025, 8 a.m. - OSE Immunotherapeutics SA ( ISIN: FR0012127173; Mnemo: OSE) announces the publication [...]
Ose Immunotherapeutics : Mise à disposition des documents préparatoires à l’Assemblée générale mixte du 25 juin 2025
04/06/2025
Mise à disposition des documents préparatoires à l’Assemblée générale mixte du 25 juin 2025 Nantes, le 4 juin 2025, 8 heures – OSE Immunotherapeutics SA ( ISIN: FR0012127173; Mnémo: OSE) annonce la mise en ligne des [...]
Ex dividend NOK 1.25 today
04/06/2025
The shares in Vistin Pharma ASA (VISTN) will be traded ex dividend NOK 1.25 as from today, 04.06.2025.
Roche’s Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)
04/06/2025
Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SMA Evrysdi offers the same efficacy and safety demonstrated in available oral solution [...]
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
04/06/2025
Saint-Herblain (France), June 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today announced the availability of documentation for its Combined General Meeting (“ [...]
Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction
04/06/2025
Saint-Herblain (France), le 4 juin 2025 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA) (la « Société »), société spécialisée dans les vaccins, a annoncé aujourd’hui la mise à disposition des documents préparatoires [...]
World's Leading Institutions and IBA launch Proton Therapy Academy to shape the future of cancer care
04/06/2025
New global education initiative unveiled at 2025 PTCOG Annual Conference Louvain-la-Neuve, Belgium, 4 June 2025 - IBA (Ion Beam Applications SA), the world leader in particle accelerator technology and the world’s [...]
Des institutions mondiales de renom et IBA lancent la Proton Therapy Academy pour élaborer l'avenir des soins contre le cancer
04/06/2025
Nouvelle initiative mondiale de formation présentée lors de la conférence annuelle PTCOG 2025 Louvain-la-Neuve, Belgique, le 4 juin 2025 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d [...]
Merus N.V. Announces Pricing of Public Offering of Common Shares
04/06/2025
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific [...]
More Than a Symposium: IOF Builds Momentum Toward the Future of Orthodontics
04/06/2025
HONG KONG, June 03, 2025 (GLOBE NEWSWIRE) -- The International Orthodontics Foundation (IOF), in collaboration with the ADA Forsyth Institute (AFI) and the Complutense University of Madrid (UCM), will host the 2025 IOF- [...]
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards
04/06/2025
VALENCIA, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering a portfolio of transformative solutions, today announced that [...]
Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA
03/06/2025
Best-in-disease profile with JAK-like efficacy and monthly (Q4W) dosing in both three-month placebo-controlled and six-month blinded treatment period Favorable safety and tolerability, particularly when compared to [...]
InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer
03/06/2025
Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) MIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid [...]
Merus N.V. Announces Proposed Public Offering of Common Shares
03/06/2025
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific [...]
Windtree Announces Plan for Cryptocurrency Treasury Policy
03/06/2025
Windtree intends to accept cryptocurrency as an option for payment and also to hold as an asset WARRINGTON, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: [...]
Bicara Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
03/06/2025
BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
HealthEquity Reports First Quarter Ended April 30, 2025 Financial Results
03/06/2025
Highlights of the first quarter include: Revenue of $330.8 million, an increase of 15% compared to $287.6 million in Q1 FY25. Net income of $53.9 million, an increase of 87% compared to $28.8 million in Q1 FY25, with [...]
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
03/06/2025
VANCOUVER, British Columbia and BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering [...]
Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer
03/06/2025
TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“ Teva ”) announced today the pricing and early acceptance results of its previously announced tender offers [...]

Pages